930539 Clinical evaluation of HBV HCV andHDV serum markers in patients with liver cir-rhosis(LC)and hepatoeellular cacinoma(HCC).ZENG Weizheng(曾维政),et al.lstDept Intern Med,General Hosp,Chengdu Com-mand,Chengdu,610...930539 Clinical evaluation of HBV HCV andHDV serum markers in patients with liver cir-rhosis(LC)and hepatoeellular cacinoma(HCC).ZENG Weizheng(曾维政),et al.lstDept Intern Med,General Hosp,Chengdu Com-mand,Chengdu,610083.Chin J Intern Med1993;32(3):167—169.Eleven kinds of HBV,HCV and HDV serummarkers were investigated in 46 patients withHCC,48 patients with LC,and 52 controls with-out liver disease.The prevalence of one out ofHBV or HCV or HDV markers(M)in HCC andLC was 91.3% and 95.8% respectively,signifi-cantly higher than that in controls(17. 3%).Positivity of HBV—M in HCC and LC was re-markably higher than that of HCV—M and展开更多
文摘930539 Clinical evaluation of HBV HCV andHDV serum markers in patients with liver cir-rhosis(LC)and hepatoeellular cacinoma(HCC).ZENG Weizheng(曾维政),et al.lstDept Intern Med,General Hosp,Chengdu Com-mand,Chengdu,610083.Chin J Intern Med1993;32(3):167—169.Eleven kinds of HBV,HCV and HDV serummarkers were investigated in 46 patients withHCC,48 patients with LC,and 52 controls with-out liver disease.The prevalence of one out ofHBV or HCV or HDV markers(M)in HCC andLC was 91.3% and 95.8% respectively,signifi-cantly higher than that in controls(17. 3%).Positivity of HBV—M in HCC and LC was re-markably higher than that of HCV—M and
